Search results for "indication"

showing 10 items of 114 documents

Intra-arterial idarubicin_lipiodol without embolization can provide prolonged complete response in hepatocellular carcinoma: A case report.

2020

International audience; Hepatocellular carcinoma is the fourth leading cause of cancer death. For unresectable intermediate-stage hepatocellular carcinoma, the standard treatment is transarterial chemoembolization. To date, the overall survival at three years remains low, and there is currently no consensus about the best anticancer agent and optimal treatment regimen. We report the case of a hepatocellular carcinoma patient with a vascular contraindication to embolization who achieved a complete response after four intra-arterial infusions of idarubicin emulsified with lipiodol. The patient maintained his response over a three-year period without any hepatocellular carcinoma treatment, dem…

MaleHepatocellular carcinoma[SDV.IB.IMA]Life Sciences [q-bio]/Bioengineering/Imagingmedicine.medical_treatmentGastroenterologyEthiodized Oil0302 clinical medicineMESH: Infusions Intra-ArterialMESH: Liver NeoplasmsPharmacology (medical)EmbolizationMESH: Carcinoma HepatocellularComplete responseMESH: Treatment OutcomeMESH: AgedStandard treatmentLiver Neoplasms[SDV.SP]Life Sciences [q-bio]/Pharmaceutical sciences3. Good healthTreatment OutcomeOncology030220 oncology & carcinogenesisHepatocellular carcinomaLipiodol030211 gastroenterology & hepatologymedicine.drugmedicine.medical_specialtyIntra-arterial therapyCarcinoma HepatocellularAntineoplastic Agents[SDV.CAN]Life Sciences [q-bio]/Cancer03 medical and health sciencesMESH: Ethiodized OilInternal medicinemedicineHumansInfusions Intra-ArterialIdarubicinContraindicationAgedMESH: Humansbusiness.industryMESH: Idarubicinmedicine.diseasedigestive system diseasesMESH: MaleRegimenMESH: Antineoplastic AgentsbusinessIdarubicin
researchProduct

Relative advantages and disadvantages of radical perineal prostatectomy versus radical retropubic prostatectomy

2002

In recent years prostate cancer has become the predominant malignancy in men. With the introduction of prostate specific antigen (PSA) the disease can be diagnosed at an early stage, at which surgical therapy can be curative. In the past century, the retropubic and the perineal routes were established as alternatives of surgical access to the gland for clinically localized prostate cancer. The selection of the operative route is mostly decided individually on the basis of surgical training and experience. The revived interest in perineal radical prostatectomy is explained by the fact that this technique has been associated with low morbidity. The differences of both surgical approaches of r…

MaleProstatectomymedicine.medical_specialtyProstatectomybusiness.industryContraindicationsmedicine.medical_treatmentProstatic NeoplasmsHematologyPerineumMalignancymedicine.diseasePerineumSurgeryProstate-specific antigenProstate cancerPostoperative Complicationsmedicine.anatomical_structureOncologyProstatemedicineHumansbusinessRadical perineal prostatectomyRadical retropubic prostatectomyCritical Reviews in Oncology/Hematology
researchProduct

Endovascular treatment of large and wide aortic neck: case report and literature review

2017

Large (24–34 mm) and wide (≥35 mm) aortic necks are a contraindication to endovascular aneurysm repair (EVAR). A 63-year-old man, unfit for conventional surgery, presented a 79 mm abdominal aortic aneurysm with 36.5 mm aortic neck and a 62 mm right common iliac artery aneurysm. He was treated endovascularly with standard commercially available stent-graft using the so-called ‘funnel technique’; by placing a thoracic stent-graft inside a bifurcated device to achieve proximal sealing. The completion angiography and the 6 months follow-up with computed tomography showed no stent-graft migration, limb occlusion or endoleak. The literature review reported 179 cases of large aortic neck managed w…

MalePulmonary and Respiratory Medicinemedicine.medical_specialtyTime FactorsEndoleakTime Factormedicine.medical_treatmentRight Common Iliac Artery030204 cardiovascular system & hematologyEndovascular aneurysm repairSettore MED/22 - Chirurgia Vascolare030218 nuclear medicine & medical imaging03 medical and health sciencesBlood Vessel Prosthesis Implantation0302 clinical medicineAneurysmOcclusionmedicineStentHumanscardiovascular diseasesComplications; Endoleak; Funnel technique; Large neck; Migration; Aortic Aneurysm Abdominal; Blood Vessel Prosthesis Implantation; Endovascular Procedures; Humans; Male; Middle Aged; Time Factors; Tomography X-Ray Computed; Stents; Surgery; Pulmonary and Respiratory Medicine; Cardiology and Cardiovascular MedicineContraindicationMigrationEndovascular Proceduremedicine.diagnostic_testLarge neckbusiness.industryEndovascular ProceduresGeneral MedicineMiddle Agedmedicine.diseaseAbdominal aortic aneurysmSurgerysurgical procedures operativeAngiographycardiovascular systemStentsSurgeryAortic neckbusinessFunnel techniqueTomography X-Ray ComputedCardiology and Cardiovascular MedicineComplicationAortic Aneurysm AbdominalHuman
researchProduct

Risk factors for resurgery in men with artificial urinary sphincter: Role of urethral strictures

2017

Objective: The aims of the present study were to evaluate the outcome of implantation of an artificial urinary sphincter (AUS) in male patients with iatrogenic urinary incontinence and to analyse possible risk factors for resurgery, with particular focus on the effects of posterior urethral strictures (US). Methods: The outcomes of AUS implantation surgeries performed by 2 surgeons on consecutive patients between January 1999 and 2015 were evaluated retrospectively. Univariate analysis with Cox proportional hazard regression was used to assess correlations between resurgery (explantation or substitution of the urethral cuff) and risk factors. Hazard ratios (HR) associated with AUS survival …

MaleReoperationMale incontinencemedicine.medical_specialtyUrology030232 urology & nephrologyUrinary incontinenceArtificial urinary sphincter03 medical and health sciences0302 clinical medicineRisk FactorsmedicineHumansContraindicationSurvival analysisAgedProportional Hazards ModelsRetrospective StudiesAged 80 and overUrethral StrictureUnivariate analysisIncontinence030219 obstetrics & reproductive medicinebusiness.industryHazard ratioMiddle AgedArtificial urinary sphinctermedicine.diseaseSurgeryStenosisUrinary IncontinenceNeurologyRelative riskUrinary Sphincter Artificialmedicine.symptombusiness
researchProduct

Sudden severe abdominal pain after a single low dose of paracetamol/codein in a cholecystectomized patient: learning from a case report.

2009

We report the case of an elderly patient with diastolic heart failure and renal insufficiency admitted to hospital as he complained of having a history of hypogastric pain and dysuria without fever due to renal lithiasis and urinary infection. Because the pain was persistence, and considering the presence of renal dysfunction, it was administered a single low dose of paracetamol/codein (500/30 mg). After about 1 hour of the administration, he suddenly complained of the onset of a lancinating epigastric pain radiating to the whole abdomen and retrosternum accompanied by nausea. The electrocardiogram (EKG) was negative for myocardial infarction and computed tomography excluded aortic dissecti…

MaleSpasmmedicine.medical_specialtyAbdominal painmedicine.medical_treatmentabdominal pain paracetamolSeverity of Illness IndexEpigastric painSphincter of OddimedicineHumansDysuriaCholecystectomyPharmacology (medical)Sphincter of OddiContraindicationAcetaminophenAgedPharmacologyCodeinebusiness.industryGeneral MedicineAnalgesics Non-Narcoticmedicine.diseaseAbdominal PainSurgeryAnalgesics OpioidDrug CombinationsAcute abdomenAnesthesiaAcute pancreatitisCholecystectomymedicine.symptombusiness
researchProduct

Is metal accumulation in Pomphorhynchus laevis dependent on parasite sex or infrapopulation size?

2010

SUMMARYConcentrations of the elements As, Cd, Co, Cu, Fe, Mn, Mo, Ni, Pb, Sn, V, Zn were analysed by inductively coupled plasma mass spectrometry (ICP-MS) in the acanthocephalan Pomphorhynchus laevis and its fish host Barbus barbus. A total of 27 barbels were collected from the Danube River in autumn 2006 close to the town Kozloduy (685 river kilometer) on the Bulgarian river bank. Fish were divided into 3 groups. According to their P. laevis infrapopulation size hosts were considered as heavily infected (>100 worms per fish) and lightly infected (<20 worms per fish). The third group was used to compare heavy metal concentrations between male and female P. laevis. The 5 elements As, C…

Male[ SDV.MP.PAR ] Life Sciences [q-bio]/Microbiology and Parasitology/ParasitologyCyprinidaechemistry.chemical_elementZoology[ SDV.TOX.ECO ] Life Sciences [q-bio]/Toxicology/EcotoxicologyBioconcentrationMass SpectrometryAcanthocephalaHost-Parasite InteractionsPomphorhynchus laevisFish DiseasesSex FactorsMetals Heavy[ SDV.EE.IEO ] Life Sciences [q-bio]/Ecology environment/SymbiosisAnimalsParasite hostingpollutionTissue DistributionIntestinal Diseases ParasiticBulgariaheavy metalsinductively coupled plasma mass spectrometryPopulation DensityBarbelCadmiumbiologyEcologybiology.organism_classificationBarbus barbusbioindicationBarbus barbusInfectious DiseasesbioaccumulationchemistryBioaccumulationFemaleAnimal Science and ZoologyParasitologyPomphorhynchus laevisHelminthiasis AnimalAcanthocephalaBiologieWater Pollutants ChemicalEnvironmental Monitoring
researchProduct

Reduced Rivaroxaban Dose Versus Dual Antiplatelet Therapy After Left Atrial Appendage Closure: ADRIFT a Randomized Pilot Study.

2020

Background: Percutaneous left atrial appendage closure (LAAC) exposes to the risk of device thrombosis in patients with atrial fibrillation who frequently have a contraindication to full anticoagulation. Thereby, dual antiplatelet therapy (DAPT) is usually preferred. No randomized study has evaluated nonvitamin K antagonist oral anticoagulant after LAAC, and we decided to evaluate the efficacy and safety of reduced doses of rivaroxaban after LAAC. Methods: ADRIFT (Assessment of Dual Antiplatelet Therapy Versus Rivaroxaban in Atrial Fibrillation Patients Treated With Left Atrial Appendage Closure) is a multicenter, phase IIb study, which randomized 105 patients after successful LAAC to eith…

Malemedicine.medical_specialtyCardiac CatheterizationPercutaneousTime FactorsAntithrombin IIIAtrial AppendagePilot Projects030204 cardiovascular system & hematologyFibrin Fibrinogen Degradation Products03 medical and health sciences0302 clinical medicineFibrinolytic AgentsRivaroxabanLeft atrialHeart RateInternal medicineAtrial FibrillationMedicineHumansAtrial Appendage030212 general & internal medicineContraindicationBlood CoagulationAgedAppendageAged 80 and overRivaroxabanbusiness.industryDual Anti-Platelet TherapyAtrial fibrillationThrombosisClopidogrelmedicine.diseasePeptide Fragments3. Good healthTreatment OutcomeCardiologyAtrial Function LeftFemaleProthrombinFranceCardiology and Cardiovascular MedicinebusinessBiomarkersPlatelet Aggregation Inhibitorsmedicine.drugFactor Xa InhibitorsPeptide HydrolasesCirculation. Cardiovascular interventions
researchProduct

Percutaneous closure of left atrial appendage to prevent embolic events in high-risk patients with chronic atrial fibrillation

2009

Background: Percutaneous closure of the left atrial appendage (LAA) is a novel alternative for the treatment of patients with atrial fibrillation (AF) and with a high risk of stroke who are not eligible for long-term anticoagulation therapy. The aim of this study was to asses the safety, feasibility, and long-term efficacy of this procedure. Methods: From July 2004 to June 2007, 20 patients (13 male, mean age 69 ± 8 years) with non–valvular AF (NV-AF) underwent LAA percutaneous closure using the PLAATO™ system, implanted through a transeptal access. All patients had contraindications to anticoagulant therapy and were at high risk for cardioembolic stroke (mean CHADS2 score 3 ± 1.2). A trans…

Malemedicine.medical_specialtyCardiac CatheterizationPercutaneousTime FactorsThromboembolism.left atrial appendage occlusionmedicine.medical_treatmentEmbolismSettore MED/11 - Malattie dell'Apparato CardiovascolareTransesophagealLeft atrial appendage occlusionPericardial effusionRisk AssessmentLeft atrialInternal medicineAtrial FibrillationmedicineHumansRadiology Nuclear Medicine and imagingAtrial Appendageatrial fibrillation; left atrial appendage occlusion; thromboembolism; Aged; Atrial Fibrillation; Contraindications; Echocardiography Transesophageal; Embolism; Equipment Design; Feasibility Studies; Female; Humans; Male; Middle Aged; Platelet Aggregation Inhibitors; Risk Assessment; Stroke; Time Factors; Treatment Outcome; Anticoagulants; Atrial Appendage; Cardiac Catheterization; Chronic DiseaseStrokeAgedbusiness.industryContraindicationsAnticoagulantsAtrial fibrillationGeneral MedicineEquipment DesignthromboembolismMiddle Agedmedicine.diseaseSurgeryStrokeTreatment OutcomePericardiocentesisEchocardiographyChronic DiseaseCardiologyPatent foramen ovaleFeasibility StudiesFemaleCardiology and Cardiovascular MedicinebusinessEchocardiography TransesophagealPlatelet Aggregation Inhibitors
researchProduct

[Contraception in chronically ill adolescents].

2003

Contraception in chronically ill adolescents has to consider side effects with regard to metabolic or hematological disease. Additionally the compliance of the patient has to be taken in account when consulting about contraceptives. In juvenile diabetics with good glycemic control and metabolic diseases of the amino acids oral contraceptives are justifiable. Adolescents with galactose-mia mostly suffer from premature ovarian failure and therefore have to be controlled wether they need contraception at all. Young women with sickle-cell anemia are at risk of thrombophilia. They should not be given hormonal contraceptives. In v. Willebrand-Jurgens-Syndrome oral contraceptives are favourable be…

Malemedicine.medical_specialtyPediatricsAdolescentAnemiaSexual BehaviorDiseaseThrombophiliaDiabetes mellitusmedicineHumansGlycemicGynecologybusiness.industryContraindicationsObstetrics and Gynecologymedicine.diseasePremature ovarian failureChronic diseaseContraceptionDiabetes Mellitus Type 1Sexual behaviorChronic DiseaseFemalebusinessSexualityContraceptives OralZentralblatt fur Gynakologie
researchProduct

Cisternostomy: A Timely Intervention in Moderate to Severe Traumatic Brain Injuries: Rationale, Indications, and Prospects.

2019

Traumatic brain injury (TBI) represents a major public health concern worldwide, with no significant change in its epidemiology over the last 30 years. After TBI, the primary injury induces irreversible brain damage, which is untreatable. The subsequent secondary injury plays a critical role in the clinical prognosis because without effective treatment it will provide additional tissue damage. The resulting scenario is the rise in intracranial pressure (ICP) with the development of progressive neurological deficits. Current optimal management is based on a progressive, target-driven approach combining both medical and surgical treatment strategies among which is decompressive hemicraniectom…

Moderate to severemedicine.medical_specialtyDecompressive CraniectomyMicrosurgeryTraumatic brain injuryOstomyBrain damageNeurosurgical ProceduresContraindications Procedure03 medical and health sciencesTraumatic brain injury0302 clinical medicineIntervention (counseling)EpidemiologyBrain Injuries TraumaticMedical IllustrationmedicineHumansDecompressive hemicraniectomyIntensive care medicineIntracranial pressureDecompressive hemicraniectomybusiness.industrymedicine.diseaseCisternostomynervous system diseases030220 oncology & carcinogenesisDrainageSurgeryGlymphatic systemNeurology (clinical)medicine.symptomIntracranial Hypertensionbusiness030217 neurology & neurosurgeryWorld neurosurgery
researchProduct